Creative Medical Technology Holdings, Inc. Fair Value Adjustment of Warrants
Creative Medical Technology Holdings, Inc. (CELZ) reported Fair Value Adjustment of Warrants of -$4.40 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2020-05-15
- Creative Medical Technology Holdings, Inc. fair value adjustment of warrants for the quarter ending 2020-03-31 was -$4.40M.
- Creative Medical Technology Holdings, Inc. fair value adjustment of warrants for the quarter ending 2019-12-31 was $4.43M.
- Creative Medical Technology Holdings, Inc. fair value adjustment of warrants for the quarter ending 2019-09-30 was $1.61M, a 75.64% increase year-over-year.
- Creative Medical Technology Holdings, Inc. fair value adjustment of warrants for the quarter ending 2019-06-30 was -$691.48K, a 110.88% decline year-over-year.
- Creative Medical Technology Holdings, Inc. fair value adjustment of warrants for fiscal 2019 was $5.09M, a 56.06% decline from fiscal 2018.
- Creative Medical Technology Holdings, Inc. fair value adjustment of warrants for fiscal 2018 was $11.59M, a 949.95% increase from fiscal 2017.
- Creative Medical Technology Holdings, Inc. fair value adjustment of warrants for fiscal 2017 was $1.10M.
- Creative Medical Technology Holdings, Inc. fair value adjustment of warrants for fiscal 2016 was $0.00.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$4.40M 10-Q · filed 2020-05-15 | $33.43K derived: sum of 2 quarters · filed 2020-05-15 | $1.65M derived: sum of 3 quarters · filed 2020-05-15 | $956.36K derived: sum of 4 quarters · filed 2020-05-15 |
| 2019-12-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $6.05M derived: sum of 2 quarters · filed 2020-04-06 | $5.36M derived: sum of 3 quarters · filed 2020-04-06 | $5.09M 10-K · filed 2020-04-06 |
| 2019-09-30 | $1.61M 10-Q · filed 2019-11-14 | $922.93K derived: sum of 2 quarters · filed 2019-11-14 | $657.76K 10-Q · filed 2019-11-14 | -$2.07M derived: sum of 4 quarters · filed 2020-05-15 |
| 2019-06-30 | -$691.48K 10-Q · filed 2019-08-13 | -$956.65K 10-Q · filed 2019-08-13 | -$3.68M derived: sum of 3 quarters · filed 2020-05-15 | -$2.76M derived: sum of 4 quarters · filed 2020-05-15 |
| 2019-03-31 | -$265.17K 10-Q · filed 2020-05-15 | -$2.99M derived: sum of 2 quarters · filed 2020-05-15 | -$2.07M derived: sum of 3 quarters · filed 2020-05-15 | $4.29M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | -$2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | -$1.80M derived: sum of 2 quarters · filed 2020-04-06 | $4.55M derived: sum of 3 quarters · filed 2020-04-06 | $11.59M 10-K · filed 2020-04-06 |
| 2018-09-30 | $919.15K 10-Q · filed 2019-11-14 | $7.27M derived: sum of 2 quarters · filed 2019-11-14 | $14.31M 10-Q · filed 2019-11-14 | $15.36M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $6.36M 10-Q · filed 2019-08-13 | $13.39M 10-Q · filed 2019-08-13 | $14.44M derived: sum of 3 quarters · filed 2019-08-13 | $14.07M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $7.04M 10-Q · filed 2019-05-20 | $8.09M derived: sum of 2 quarters · filed 2019-05-20 | $7.71M derived: sum of 3 quarters · filed 2019-05-20 | $8.14M derived: sum of 4 quarters · filed 2019-05-20 |
| 2017-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $676.59K derived: sum of 2 quarters · filed 2019-04-01 | $1.10M derived: sum of 3 quarters · filed 2019-04-01 | $1.10M 10-K · filed 2019-04-01 |
| 2017-09-30 | -$372.60K 10-Q · filed 2018-11-14 | $54.53K derived: sum of 2 quarters · filed 2018-11-14 | $54.53K 10-Q · filed 2018-11-14 | $54.53K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $427.13K 10-Q · filed 2018-08-14 | $427.13K 10-Q · filed 2018-08-14 | $427.13K derived: sum of 3 quarters · filed 2018-08-14 | $427.13K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $0.00 10-Q · filed 2018-08-03 | $0.00 derived: sum of 2 quarters · filed 2018-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-08-03 | $0.00 derived: sum of 4 quarters · filed 2018-08-03 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 derived: sum of 2 quarters · filed 2018-03-29 | $0.00 derived: sum of 3 quarters · filed 2018-03-29 | $0.00 10-K · filed 2018-03-29 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2017-11-13 | $0.00 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |